Overview Fundamentals API Earnings EOD API Sample Code Pricing

RAPT Therapeutics Inc (RAPT NASDAQ) stock market data APIs

$3.62 0.19(5.5%) as of July 18, 2024
Price chart is built with Anychart

RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases in the United States. The company's lead inflammation drug candidate is zelnecirnon (RPT193), a C-C motif chemokine receptor 4 (CCR4) antagonist that selectively inhibit the migration of type 2 T helper cells into inflamed tissues. Its lead oncology drug candidate is tivumecirnon (FLX475), an oral small molecule CCR4 antagonist that is in the Phase 1/2 clinical trial to investigate as a monotherapy and in combination with pembrolizumab in patients with advanced cancer. The company was formerly known as FLX Bio, Inc. and changed its name to RAPT Therapeutics, Inc. in May 2019. RAPT Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California. RAPT Therapeutics, Inc. operates as a subsidiary of Bristol-Myers Squibb Company

RAPT Therapeutics Inc Financial Data Overview

3.43
3.62
-
3.7
3.39
2.61-27.35
127 M
34 904 K
0
-0.79
0.358
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'RAPT',
Type: 'Common Stock',
Name: 'RAPT Therapeutics Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00PGK50M2',
ISIN: NULL,
CUSIP: NULL,
CIK: '1673772',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2019-10-31',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

RAPT Therapeutics Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -126 787 000
  • Earnings Per Share -3.08
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get RAPT Therapeutics Inc Earnings via APIs

  • Latest Release 2024-05-09
  • EPS/Forecast -0.81

Get RAPT Therapeutics Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com